Clario's Precision Motion Opal® technology powers University of Oxford breakthrough in Parkinson's Disease

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Clario-Opal

More Like This

PR Newswire associated0

Clario joins forces with Mobilise-D to advance Digital Mobility Outcomes in clinical trials

PR Newswire associated0

Clario presents a three-part webinar series on oncology trial solutions

PR Newswire associated0

Clario and Cleveland Clinic's Cole Eye Institute announce strategic partnership to provide new ophthalmology offerings for clinical trials

PR Newswire associated0

QuantalX Introduces a Breakthrough in the Diagnosis and Classification of Parkinson's Disease

PR Newswire associated0

Clario Collaborates with AWS to Push New Boundaries in Clinical Data Analysis with Generative AI

PR Newswire associated0

Clario's New AI-Powered ECG Quality Score Tool Enhances Cardiac Safety Assessments

PR Newswire associated0

Clario announces acquisition of imaging provider NeuroRx

PR Newswire associated0

Clario teams up with CellCarta to transform clinical trial sample management for histopathology studies